what is going on with compounded tirzepatide FDA ban on compounded tirzepatide:
Description
The cost of a new vial is not worth the risk of injecting glass fragments
Hypoglycemia is rare with monotherapy but can occur if combined with insulin or sulfonylureas
While these substances were always prohibited as anabolic agents, the explicit naming removes any ambiguity for athletes, their support personnel, and testing laboratories
Not A Medical Referral Service
Syringe Volume Selection Compounded syringes typically come in 0.3cc or 1cc volumes
